Intuitive Surgical Stock Surges as Demand Grows for Latest Robotic Surgeon

Welcome to Extreme Investor Network, where we bring you the latest updates and insights on the world of finance. Today, we’re diving into the exciting news surrounding Intuitive Surgical (ISRG) stock.

Intuitive Surgical recently made headlines by beating first-quarter expectations and launching its next-generation system, the da Vinci 5. This robotic surgery behemoth received FDA clearance for its new system on March 14, and in just two weeks, they had already placed eight new systems. The rapid placements indicate a high demand for the da Vinci 5 following its “measured” launch.

“We are pleased by the feedback from our measured da Vinci 5 launch as well as the continued adoption of SP (single-port) and Ion (for lung biopsies), and we remain focused on delivering the goals we share with our customers, including improving patient outcomes,” said Chief Executive Gary Guthart.

Related:  Cramer criticizes DOJ's lawsuit against Apple but still recommends buying the stock

In after-hours trading, Intuitive Surgical stock rose 1.7% to 379, showing positive momentum following their successful first-quarter results. The company reported earnings of $1.50 per share on $1.89 billion in sales, surpassing expectations and demonstrating impressive growth in both earnings and sales.

Notably, the number of procedures performed using the da Vinci systems increased by 16% year over year, leading to a 35% growth in sales of instruments and accessories. While systems revenue saw a slight slowdown, it still exceeded analysts’ expectations.

As the market continues to evolve, staying informed and ahead of the curve is essential for investors. At Extreme Investor Network, we provide valuable insights and analysis to help you navigate the ever-changing landscape of finance. Stay tuned for more updates and market trends as we continue to guide you on your investment journey.

Related:  Rivian, Micron Technology, Adobe, Ulta Beauty and many others

Remember to follow us on X, formerly known as Twitter, for real-time updates and expert tips. And don’t forget to check out our recommended reads on Abbott, ResMed, options trading, and more for valuable insights on the market.

Stay ahead of the game with Extreme Investor Network. Happy investing!

Source link